Martingale Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.12M	Buy	27,538 +4,050	+17%	+$316K	0.05%	337
2025 Q4	$1.85M	Sell	23,488 -226	-1%	-$19.6K	0.05%	330
2025 Q3	$2.17M	Sell	23,714 -400	-2%	-$32.6K	0.05%	295
2025 Q2	$1.57M	Buy	24,114 +499	+2%	+$32.5K	0.04%	356
2025 Q1	$1.58M	Sell	23,615 -2,562	-10%	-$153K	0.04%	358
2024 Q4	$1.45M	Sell	26,177 -8,563	-25%	-$492K	0.04%	387
2024 Q3	$2.07M	Buy	34,740 +13,719	+65%	+$837K	0.05%	302
2024 Q2	$1.34M	Buy	21,021 +2,590	+14%	+$168K	0.03%	388
2024 Q1	$1.27M	Buy	18,431 +1,411	+8%	+$85.2K	0.03%	411
2023 Q4	$938K	Hold	17,020	–	–	0.02%	464
2023 Q3	$988K	Sell	17,020 -1	-0%	-$58	0.02%	437
2023 Q2	$916K	Buy	17,021 +800	+5%	+$35.5K	0.02%	472
2023 Q1	$644K	Hold	16,221	–	–	0.01%	555
2022 Q4	$653K	Buy	16,221 +295	+2%	+$11.1K	0.01%	572
2022 Q3	$513K	Buy	15,926 +3,100	+24%	+$106K	0.01%	617
2022 Q2	$381K	Buy	12,826 +2,517	+24%	+$72.6K	0.01%	703
2022 Q1	$290K	Buy	10,309 +801	+8%	+$29.9K	﹤0.01%	730
2021 Q4	$439K	Buy	+9,508	New	+$409K	0.01%	674
2020 Q4	–	Sell	-23,809	Closed	-$673K	–	875
2020 Q3	$673K	Sell	23,809 -26,700	-53%	-$795K	0.01%	735
2020 Q2	$1.64M	Sell	50,509 -4	-0%	-$143	0.02%	592
2020 Q1	$2.06M	Buy	50,513 +10,301	+26%	+$548K	0.03%	482
2019 Q4	$2.48M	Sell	40,212 -5,400	-12%	-$358K	0.03%	545
2019 Q3	$3.33M	Buy	45,612 +3,001	+7%	+$225K	0.03%	472
2019 Q2	$3.5M	Buy	42,611 +15,502	+57%	+$1.1M	0.04%	465
2019 Q1	$1.91M	Buy	27,109 +3,800	+16%	+$224K	0.02%	614
2018 Q4	$1.05M	Buy	+23,309	New	+$1.22M	0.01%	706